We are live on
!
Find out more
Vertex Pharmaceuticals
VRTX
VRTX
483 hedge funds and large institutions have $17.4B invested in Vertex Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 172 increasing their positions, 191 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
95.29% more ownership
Funds ownership: 0% → 95.29% (+95%)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
9% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 56
5% less call options, than puts
Call options by funds: $117M | Put options by funds: $123M
10% less repeat investments, than reductions
Existing positions increased: 172 | Existing positions reduced: 191
1% less funds holding
Funds holding: 489 → 483 (-6)
17% less capital invested
Capital invested by funds: $20.9B → $17.4B (-$3.46B)
Holders
483
Holders Change
-6
Holders Change %
-1.23%
% of All Funds
12.08%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
61
Increased
172
Reduced
191
Closed
56
Calls
$117M
Puts
$123M
Net Calls
-$5.9M
Net Calls Change
-$13.6M
Top Buyers
Top Sellers
| 1 |
Jennison Associates
New York
|
-$316M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$231M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$132M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$125M |
| 5 |
O
OppenheimerFunds
New York
|
-$83.3M |
